Nutrien (NYSE:NTR) Price Target Raised to $74.00

Nutrien (NYSE:NTRFree Report) had its price objective upped by Raymond James Financial from $68.00 to $74.00 in a research note published on Friday morning,BayStreet.CA reports. They currently have a market perform rating on the stock.

Other equities analysts have also recently issued research reports about the company. Mizuho boosted their price objective on Nutrien from $65.00 to $68.00 and gave the company a “neutral” rating in a report on Friday, January 16th. TD Securities upped their price objective on shares of Nutrien from $80.00 to $81.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. UBS Group increased their target price on shares of Nutrien from $58.00 to $63.00 and gave the stock a “neutral” rating in a research note on Monday, January 12th. Morgan Stanley upgraded Nutrien from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $70.00 to $77.00 in a research note on Wednesday, January 14th. Finally, Wells Fargo & Company upped their price target on Nutrien from $64.00 to $77.00 and gave the stock an “equal weight” rating in a report on Friday. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Nutrien presently has an average rating of “Moderate Buy” and an average price target of $70.11.

Read Our Latest Stock Report on NTR

Nutrien Trading Down 0.8%

Shares of NYSE:NTR opened at $71.19 on Friday. Nutrien has a 52-week low of $45.78 and a 52-week high of $73.55. The company has a quick ratio of 0.70, a current ratio of 1.34 and a debt-to-equity ratio of 0.37. The stock has a market cap of $34.27 billion, a price-to-earnings ratio of 15.28 and a beta of 0.73. The business has a 50-day moving average price of $66.23 and a 200-day moving average price of $60.68.

Nutrien (NYSE:NTRGet Free Report) last announced its quarterly earnings data on Wednesday, February 18th. The company reported $0.83 EPS for the quarter, missing the consensus estimate of $0.87 by ($0.04). The business had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The business’s revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.31 earnings per share. Equities analysts predict that Nutrien will post 3.72 EPS for the current year.

Nutrien Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be paid a $0.55 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.20 annualized dividend and a yield of 3.1%. This is an increase from Nutrien’s previous quarterly dividend of $0.55. Nutrien’s dividend payout ratio is currently 46.78%.

Institutional Investors Weigh In On Nutrien

A number of large investors have recently modified their holdings of NTR. Wellington Management Group LLP raised its position in shares of Nutrien by 440.2% in the fourth quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company’s stock valued at $1,008,713,000 after buying an additional 13,313,817 shares during the last quarter. Norges Bank purchased a new position in Nutrien in the 2nd quarter worth approximately $395,842,000. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Nutrien by 48.5% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,944,730 shares of the company’s stock worth $696,058,000 after purchasing an additional 3,900,755 shares during the last quarter. Boston Partners acquired a new position in shares of Nutrien during the 2nd quarter worth approximately $150,416,000. Finally, First Eagle Investment Management LLC grew its position in shares of Nutrien by 14.0% in the second quarter. First Eagle Investment Management LLC now owns 13,268,229 shares of the company’s stock valued at $772,742,000 after purchasing an additional 1,627,328 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien News Roundup

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Multiple broker upgrades and higher price targets — BMO raised its target to $85 (outperform), JPMorgan to $78 (overweight), Wells Fargo to $77 (equal weight) and Raymond James to $74, signaling analyst confidence in Nutrien’s outlook and suggesting meaningful upside from recent levels. BayStreet.CA Benzinga
  • Positive Sentiment: Shareholder returns: Nutrien raised its quarterly dividend (to $0.55) and announced a new buyback program — a direct positive for investors seeking yield and capital return. TipRanks
  • Positive Sentiment: Favorable commodity outlook: Management expects stronger global potash demand in 2026 despite difficult farm economics — a revenue/volume tailwind for Nutrien’s fertilizer segment. Reuters
  • Neutral Sentiment: Earnings materials available — full Q4 2025 call transcript and presentation have been published for investor review; useful for drilling into segment-level detail but not a directional catalyst by itself. Seeking Alpha Yahoo Finance
  • Neutral Sentiment: Some analysts remain cautious: Bank of America raised its target to $71 but kept a neutral rating (minimal implied upside). That tempers the bullish momentum from higher targets. Benzinga
  • Negative Sentiment: Operational results missed consensus: Q4 EPS came in at $0.83 vs. $0.87 expected and revenue of ~$5.12B was slightly below estimates — the earnings miss is the primary near-term negative pressure on the share price. Zacks
  • Negative Sentiment: Mixed analyst views persist — UBS assigned a “hold,” which indicates some investors and brokers are reserving judgment despite the positive catalysts. Globe & Mail

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Stories

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.